lobbying_activities: 1225329
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1225329 | 134face3-6ebe-45c9-bfa0-8caf36f27178 | Q1 | AMERICAN HEART ASSOCIATION | 2525 | AMERICAN HEART ASSOCIATION | 2012 | first_quarter | PHA | The Role of Cardiovascular Assessment in the Preapproval and Postapproval Settings for Drugs and Biologics Developed for the Treatment of Obesity (FDA-2012-N-0001) | Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Environmental Protection Agency (EPA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Treasury, Dept of | 175818 | 0 | 0 | 2012-04-12T08:58:04.580000-04:00 |